Safety and effectiveness of Traditional Chinese Medicine manipulation in early rehabilitation after arthroscopic debridement for knee osteoarthritis: a prospective randomized controlled study

适应症

试验速览

阶段: 1 期
状态: 招募中
发起方: The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

暂无简介。

•1. Participant is willing and able to give informed consent for participation in the trial.
•2. According to the clinical diagnostic criteria of the American Rheumatism Association in 1986, diagnosed with knee OA.
•3. Radiographic evidence of mild-to-moderate knee osteoarthritis (Kellgren-Lawrence grade 1-3).
•4. Suffering from one or more specific mechanical symptoms caused by loose bodies and/or meniscus tears within 3 months.
•5. No gender limits, aged 50-75 years.
•6. Able and willing to comply with all test requirements.

•1. A participant with stiffness or instability of the knee.
•2. A participant with severe acute/chronic mental diseases, anxiety or depression.
•3. A participant with tumor, infection, rheumatoid arthritis, other immune or inflammatory diseases.
•4. A participant with severe osteoporosis.
•5. A participant with histories of fracture or surgical procedure on the affected knee.
•6. A participant with hemorrhagic diseases or coagulopathy.
•7. A participant with severe hypertension, arhythmia or other cardio-cerebro vascular disease.
•8. A participant with history of receiving massage, manipulation, acupuncture, sodium hyaluronate or corticosteroid injection, or any other invasive therapy within 3 months.
•9. Pregnant or lactating women.
•10. A participant who have participated in another clinical study which may influence the result of the trial in the past 3 months.
•11. MRI showing specific signals characteristic of subchondral edema.
•12. Arthroscopically-verified full-thickness cartilage defect or marked chondral flap in the weight-bearing area.
•13. Meniscal repair, notchplasty or removal of osteophytes, any form of cartilage augmentation or removal of chondral flaps, microfracture, or extensive synoviectomy was performed in the arthroscopic surgery.
•14. Any other significant disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial.

发起方